BridgeBio CEO Neil Kumar: Our heart disease drug staves off death and hospitalization

(2:48)

Exclusive Insights: Neil Kumar on Bridge Biopharma's Global Mission in Genetic Disease

(10:36)

Founder Stories: Neil Kumar - founder and CEO of BridgeBio

(1:1:15)

Pantheon 2020 | BridgeBio

(3:38)

BridgeBio’s big week, Lilly’s Alzheimer’s data, \u0026 succession at Stanford

(35:27)

Markets face 'normalization on steroids' in 2025

(10:41)

Thomas Schinecker - CEO of Roche | Podcast | In Good Company | Norges Bank Investment Management

(51:26)

Venture Trends \u0026 2025 Outlook

(53:32)

It's still an AI bull market, the AI and chip trades aren't dead, says Deepwater's Doug Clinton

(4:59)

Bank of Canada to slow rate cuts: Paul Beaudry

(8:47)

Revolutionizing ITOps with NeuBird.ai CEO | The Future of IT Operations \u0026 Innovation | Goutham Rao

(32:55)

A Conversation with Robin Li, Baidu Co-founder \u0026 CEO

(24:5)

Elon Musk, why are you still working? You are worth $184B

(3:12)

Google CEO Sundar Pichai and the Future of AI | The Circuit

(24:2)

BridgeBio Pharma - Innovation Showcase at Ophthalmology Innovation Summit @ AAO 2019

(7:7)

BridgeBio Plunges After Acoramidis Study Fails to Meet Primary Endpoint

(1:2)

Cramer: This biotech stock could be worth over $100 billion on an FDA approval

(5:19)

Hot Picks in biopharma stocks

(5:19)

Academia + Industry with BridgeBio's Dr. Michael Henderson

(45:16)

Watch how BridgeBio uses Lever and Checkr to create an amazing candidate experience

(1:45)

Bridgebio shares surge on takeout target hopes

(3:17)

How BridgeBio’s Hub and Spoke Portfolio Strategy Set the Market for the Future of Biotech

(47:21)

🔴 BridgeBio Pharma Inc. BBIO Stock Trading Facts 🔴

(29)

LIVE- Brent Saunders, CEO, Bausch \u0026 Lomb Speaks At Miami Herbert Business School

(1:25:25)

🧨 BBIO Stock (BridgeBio Pharma stock) BBIO STOCK PREDICTIONS BBIO STOCK Analysis BBIO stock news

(1:46)

CEO of Path Joel Birch On How Crypto Can Change The Financial World | The CEO Series

(5:45)

CGT’s Main Opportunities to Meet Regulatory Requirements

(8:7)

BBIO STOCK | BRIDGEBIO PHARMA INC BIG MOVE STARTED

(1:50)